Projects per year
There is significant recent interest in the role of ginger root (Zingiber officinale)
as an adjuvant therapy for chemotherapy-induced nausea and vomiting.
This study protocol aims to assess the efficacy (reduced incidence and
severity of chemotherapy-induced nausea and vomiting, enhanced quality
of life), safety, cost-effectiveness, and impact on gut microbiota of a
standardized adjuvant ginger root supplement in adults undergoing
single-day moderate-to-highly emetogenic chemotherapy.
Multi-site, double-blind, placebo-controlled randomized trial with two parallel
arms, 1:1 allocation and target sample size of N=300. The intervention
comprises four capsules of ginger root consumed at specified times across the
day (totaling 60mg of active gingerols/day), for five consecutive days commencing
on the day of chemotherapy forCycles 1 to 3. The primary outcome
is chemotherapy-induced nausea-related quality of life measured by the
Functional Living Index – Emesis – 5 Day Recall (FLIE-5DR). Secondary
outcomes include nutrition status; anticipatory, acute and delayed nausea and
vomiting; fatigue; depression and anxiety; global quality of life; health service
use and costs. Changes to the microbiome will be examined using 16S RNA
analysis. Adverse events and adherence will also be assessed.
The SPICE trial commenced recruitment in October 2017 and is anticipated
to continue until October 2019. To date, 25 participants have been
recruited and the study appears feasible.
The research gaps addressed by the SPICE Trial may guide future recommendations
for specific ginger dosing regimens for use as an adjuvant for
chemotherapy induced nausea and vomiting prevention and management.
|Journal||Supportive Care in Cancer|
|Publication status||Published - Jun 2018|
|Event||Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO): MASCC/ISOO 2018 Annual Meeting on Supportive Care in Cancer - Vienna, Austria|
Duration: 28 Jun 2018 → 30 Jun 2018
FingerprintDive into the research topics of 'Supplemental prophylactic intervention for chemotherapy-induced nausea and emesis (spice) trial: Protocol for a multi-centre double-blind placebo-controlled randomized trial'. Together they form a unique fingerprint.
Related Research Outputs
- 1 Article
Supplemental prophylactic intervention for chemotherapy-induced nausea and emesis (SPICE) trial: Protocol for a multicentre double-blind placebo-controlled randomised trialMarx, W., McCarthy, A. L., Marshall, S., Crichton, M., Molassiotis, A., Ried, K., Bird, R., Lohning, A. & Isenring, E., 1 Feb 2020, In: Nutrition and Dietetics. 77, 1, p. 144-150 7 p.
Research output: Contribution to journal › Article › Research › peer-reviewOpen Access